Virtually all cutaneous melanomas harbor driver mutations that activate the RAS/RAF/MEK/ERK MAPK pathway [1], which facilitates the proliferation and survival of the tumor cells [2,3,4,5]. Here, RAF1 is linked to neoplasm.